Skip to content Search the desk⌘ Ctrl K Agent Sign in M Mereo BioPharma Group plc
M MREO Mereo BioPharma Group plc
M MREO Mereo BioPharma Group plc
Earnings When Mereo BioPharma Group plc reports, what it reported each quarter, and how the stock took the results.
15 quarters. Mar 31, 2023 to Sep 30, 2026. USD.
Next results · Q4 2026 Projected
Mar 18, before the open
Thu, Mar 18, 2027 in 117 days
Projected from its last 8 releases. The company has not named the day yet.
Quarter Q4 2026 · Ends about Dec 31, 2026
10-K window Mar 12 – Apr 2 Quarter by quarter 3 years 5 years
Revenue Net income EPS Operating income Operating cash flow Free cash flow
Q3 2026 $ 8 0 0 . 0 0 K $800.00K No Q3 2025 on file
Mereo BioPharma Group plc · CIK 1719714 · Engraved from SEC EDGAR
Aug 11, 2026, before the open
Revenue $0.00 −100.0%
Net income -$7.01M N/M
EPS -$0.01 N/M
Revenue — —
Net income -$6.72M N/M
EPS -$0.01 N/M
Revenue — —
Net income -$7.35M N/M
EPS — —
Results day Typical move ±6.8% A typical move of 6.8% either way
Up after 7 of 10, down after 2.
+10.0% −4.0% 0.0%
When it reports
Usual day Varies
After quarter end 41 to 78 days
10-Q filed 41 to 43 days over its last 8
10-K filed 78 to 87 days over its last 3 ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d ended Dec 31, 2024 · filed Mar 26, 2025 · 85 d ended Mar 31, 2025 · filed May 13, 2025 · 43 d ended Jun 30, 2025 · filed Aug 12, 2025 · 43 d ended Sep 30, 2025 · filed Nov 10, 2025 · 41 d ended Dec 31, 2025 · filed Mar 19, 2026 · 78 d Q2 2026 Jun 30, 2026 Aug 11, 2026 · pre-market Aug 11, 2026 42 d 10-Q $0.00 −100.0% -$0.01 +18.5%
Q1 2026 Mar 31, 2026 May 12, 2026 · pre-market May 12, 2026 42 d 10-Q — — -$0.01 +8.7%
FY 2025 Q4 2025 derived Dec 31, 2025 Mar 19, 2026 · pre-market Mar 19, 2026 78 d 10-K — — — +2.1% Q3 2025 Sep 30, 2025 Nov 10, 2025 · after-hours Nov 10, 2025 41 d 10-Q $0.00 — -$0.01 +6.5% Q2 2025 Jun 30, 2025 Aug 12, 2025 · pre-market Aug 12, 2025 43 d 10-Q $500.00K — -$0.02 +9.2% Q1 2025 Mar 31, 2025 May 13, 2025 · pre-market May 13, 2025 43 d 10-Q — — -$0.02 7.0%
FY 2024 Q4 2024 derived Dec 31, 2024 Mar 26, 2025 · pre-market Mar 26, 2025 85 d 10-K $0.00 −100.0% — 0.0% Q3 2024 Sep 30, 2024 Nov 12, 2024 · pre-market Nov 12, 2024 43 d 10-Q $0.00 — -$0.02 4.0% Q2 2024 Jun 30, 2024 Aug 13, 2024 · pre-market Aug 13, 2024 44 d 10-Q $0.00 −100.0% -$0.02 — Q1 2024 Mar 31, 2024 May 15, 2024 · after-hours May 15, 2024 45 d 10-Q $0.00 — -$0.01 —
FY 2023 Q4 2023 derived Dec 31, 2023 Mar 27, 2024 · after-hours Mar 27, 2024 87 d 10-K $1.00M — — +10.0% Q3 2023 Sep 30, 2023 — — — — $0.00 — -$0.01 — Q2 2023 Jun 30, 2023 — — — — $9.00M — $0.00 — Q1 2023 Mar 31, 2023 — — — — $0.00 — -$0.02 —
Earlier years, FY 2023 to FY 2023 The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
10-Q
May 12, 2026
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
Year over year, last four quarters
Revenue — Revenue, change from a year earlier: Q3 2026 n/m, Q2 2026 −100.0%, Q3 2025 n/m, Q2 2025 n/m n/m n/m −100.0% n/m
Net income -$7.35M Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m n/m n/m n/m n/m
EPS — EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m n/m n/m n/m n/m +4.1% by the close of Nov 9
Thaler Research Engraved from SEC EDGAR © 2026 Thaler. All rights reserved. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
+18.5% by the close of Aug 11
ended Mar 31, 2026 · filed May 12, 2026 · 42 d ended Jun 30, 2026 · filed Aug 11, 2026 · 42 d ended Sep 30, 2026 · filed Nov 9, 2026 · 40 d window Mar 12 – Apr 2 · projected Few filings are on file, so the projected window is widened until the pattern is clear.
The stock’s move from the last close before each release to the first close after it, over the last 10 releases. Largest: +18.5% after Q2 2026.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Provenance Data status and checks